Loading data for ACXP — first visit, this takes a few seconds.

알림

Acurx Pharmaceuticals Inc... (ACXP)

NasdaqCM: ACXP · 실시간 가격 · USD

1.44

-0.21 (-12.73%)

종가 기준: Aug 18, 2026, 3:59 PM

-12.73% (1D)

매수호가	1.19
시가총액	5.97M
매출 (ttm)	n/a
순이익 (ttm)	-7.51M
베타	n/a
EPS (ttm)	-2.44
P/E (ttm)	n/a
선행 P/E	-0.79
P/B (ttm)	0.80
P/S (ttm)	n/a
Earnings Date	Nov 11, 2026

매도호가	1.81
거래량	261,339
평균 거래량 (20일)	121,466
시가	1.57
전일 종가	1.65
일중 범위	1.41 - 1.65
52주 범위	1.31 - 8.34
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

ACXP 소개

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-pos...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Jun 25, 2021

직원 수 4

상장 거래소 NasdaqCM

티커 ACXP

웹사이트 https://www.acurxpharma.com

전체 기업 정보

재무 실적

2025년 Acurx Pharmaceuticals의 매출은 0로, 전년 0 대비 undefined% 증가했습니다. 순이익은 -7.97M로, -43.51% 감소했습니다.

재무제표

어닝 서프라이즈

Acurx Pharmaceuticals가 Aug 13, 2026에 분기 실적을 발표했습니다:

매출 $0 예상치 하회 $0, 및 NaN% 전년 대비 성장.

EPS -0.53 예상치 하회 -0.10, 및 71.96% 전년 대비 성장.

다음 실적 발표

Acurx Pharmaceuticals Inc.의 실적 발표 예정일은 Nov 11, 2026, 장 시작 전입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

2개월 전 · Zacks

Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's Why

Acurx Pharmaceuticals (ACXP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

3개월 전 · Moby

Acurx Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary

Moby summary of Acurx Pharmaceuticals, Inc.'s Q1 2026 earnings call

4개월 전 · Zacks

Is Acurx Pharmaceuticals (ACXP) Stock Outpacing Its Medical Peers This Year?

Here is how Acurx Pharmaceuticals, Inc. (ACXP) and Apyx Medical (APYX) have performed compared to their sector so far this year.

4개월 전 · GuruFocus.com

Acurx Pharmaceuticals Inc (ACXP) Q4 2025 Earnings Call Highlights: Financial Growth and ...

Acurx Pharmaceuticals Inc (ACXP) reports improved financial stability and significant progress in clinical trials, despite ongoing challenges.

5개월 전 · Zacks

Can Acurx Pharmaceuticals (ACXP) Climb 226.3% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for Acurx Pharmaceuticals (ACXP) points to a 226.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement...

2 페이지 중 1

Acurx Pharmaceuticals Inc... (ACXP)